Business of Biotech 7
Yale Biotechnology & Pharmaceutical Society
30 March – 2 April 2009
Constance McKee
Yale MBA 1986
President & CEO, Manzanita Pharmaceuticals, Inc.
March-April 2009
1
The Business of Biotech 7
A Non-Credit Seminar for Yale & the munity
Week of 30 March – 2 April 2009
Yale School of Management
135 Prospect Street, New Haven
Constance McKee
Yale School of Management, MBA 1986
Manzanita Pharmaceuticals, Inc.
2995 Woodside Road
Suite 400, PMB 309
Woodside, CA 94062
constance.
m v
Constance McKee
Business of Biotech 7
March-April 2009
2
Introduction
Course approach – part quantitative concepts, part case studies
First hour - basic concepts in start-ups
Modular – hard copy fills in blanks if you miss a few evenings
Second hour – micro case studies from entrepreneurs, investors & industry
Speakers talk about making decisions – and how it *really* turned out
Key questions
What’s the opportunity?
What’s the opportunity worth?
How do we – founders & investors – make money?
In the current environment, where *is* the money?
Emphasis on biopharmaceuticals
Business concepts apply to devices, tools & panies
But decision-making process similar for devices & tools
Constance McKee
Business of Biotech 7
March-April 2009
3
Course Goals
Explain challenges of raising capital for life sciences start-ups
No previous experience required
From perspective of scientist
Quantitative approach
Skip the MBA…..
Introduce basic concepts that drive the business of biotechnology
Most good business decisions are driven by quantitative concepts
Rules of the game
How to play the game to increase the probability of ess
work of Yale-centric entrepreneurs & investors
Sources of information
Sources of funding
Career opportunities outside the lab
Constance McKee
Business of Biotech 7
March-April 2009
4
Course Outline & Speakers Case Studies in Decision Making
Monday, 30 March 2009
Sohini Chowdhury, Michael J. Fox Foundation (Parkinso
Business f Biotech 7 来自淘豆网m.daumloan.com转载请标明出处.
